A year into the COVID-19 pandemic, vaccines are a reality—and now we face the logistical and medical complications of inoculating a vast population while infection rages and the virus mutates. We asked Yale SOM’s Dr. Howard Forman, a public authority on the pandemic, for an update.

Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.

We checked in with Yale SOM’s Dr. Howard Forman about herd immunity, vaccines, and that case of reinfection in Hong Kong.

Around the United States, states are easing the restrictions imposed to slow the spread of COVID-19. We asked Yale SOM’s Dr. Howard Forman if these moves are premature and what is needed for Americans to return to school and work safely. 

In a Fortune commentary, Dr. Michael Apkon ’02, president and CEO of Tufts Medical Center, and Yale SOM’s Dr. Howard Forman and Jeffrey Sonnenfeld write that such an approach would be dangerous and ineffective.

Increased testing capacity is key to unlocking greater understanding of COVID-19 and learning how to slow its spread, according to Professor Howard Forman.

We asked Yale’s Howard P. Forman, a practicing radiologist and expert in healthcare management, what’s likely to happen with coronavirus in coming days and whether the U.S. healthcare system is prepared.

What kind of leader can step in and effectively run an organization that delivers healthcare to millions of veterans? We asked Dr. Howard Forman, an expert in healthcare leadership and policy.

Yale Insights talked to Howard Forman, a Yale physician and economist, about the consequences of Congress passing a repeal of the Affordable Care Act—and what might happen if nothing passes.